ACT Brief: AI, Equity, and Innovation in Clinical Research
In the latest Applied Clinical Trials Brief, we explore advancements in clinical research, including AstraZeneca's gastric cancer care through the MATTERHORN trial.
Phesi's Gen Li discusses how AI and patient data are driving global trial equity, while the FDA introduces new draft guidance for streamlined biosimilar development.
- AstraZeneca's MATTERHORN trial redefines gastric cancer care
- AI-powered patient data improves global trial diversity
- FDA's new guidance accelerates biosimilar development
Stay updated on the latest insights in clinical research operations with the Applied Clinical Trials Brief.
Join us tomorrow for more insights shaping the future of clinical operations and drug development.
Author's summary: Clinical research advances with AI and innovation.
More News
- Choose New Jersey President and CEO Mathews to Join PSEG
- A.J. Brown, other injured Eagles have a crucial 15 days to recover thanks to bye week
- 'Love Island's' Huda Mustafa Apologizes After Laughing At Racist Slur Hurled Towards Olandria Carthen
- HSE Nursing Service unavailable on Tory Island this weekend - Donegal News
- Stephen A. Smith Questions Why Chris Grier Got Fired Before Mike McDaniel After Dolphins' Embarrassing Loss
- Loss to Bucks stunk, but Warriors' Jimmy Butler knows key to returning to 'flowers and daisies'
- Wemby’s Evolution Is Scary: Spurs Phenom Dominates Again, Leaves Heat Defenders Helpless
- Patriots' Rhamondre Stevenson is out for Sunday's game vs Falcons
- Palghar Crime News: Armed Robbers Open Fire At Jewellery Shop In Boisar, Flee Leaving Revolver Behind
- Philadelphia Eagles QB Jalen Hurts Dressed As God For Halloween